한글목차

줄기세포 시장 - 분석 범위

TMR의 조사 보고서 "세계의 줄기세포 시장"은 2025년부터 2035년까지의 예측 기간에 대한 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회에 대해서도 조사했습니다. 2025년을 기준연도, 2035년을 예측연도로 하여 2019년부터 2035년까지 세계의 줄기세포 시장의 수익과 예측을 제공합니다.

이 보고서는 광범위한 조사를 거쳐 작성되었으며, 1차 조사에서 분석가는 KOL(Key Opinion Leader), 업계 리더, 의사결정자와의 인터뷰를 실시했습니다.

본 보고서에서는 세계의 줄기세포 시장 경쟁 구도에 대해 분석했습니다.

목차

제1장 서론

제2장 전제조건과 분석방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

• 소개
• 개요
• 시장 역학
• 세계의 줄기세포 시장 분석과 예측(2020-2035년)

제5장 주요 인사이트

• 주요 업계 이벤트(파트너십, 협업, 기업 합병 및 인수(M&A) 등)
• 줄기세포의 개요
• 파이프라인 분석
• Porter's Five Forces 분석
• PESTEL 분석
• 주요국 및 지역별 규제 시나리오
• 밸류체인 분석
• 가격 동향
• 주요 경쟁이 제공하는 제품의 벤치마크
• 신규 시장 참가자를 위한 시장 개척 전략

제6장 세계 시장의 분석과 예측 : 세포유형별

• 소개 및 정의
• 주요 분석결과/진전
• 시장 예측(금액 기준) : 세포유형별(2020-2035년)
  • 배아줄기세포(ESC)
  • 간엽줄기세포(MSC)
  • 조혈줄기세포
  • 인공다능성줄기세포(iPSC)
  • 기타
• 시장의 매력 : 세포유형별

제7장 세계 시장의 분석과 예측 : 용도별

• 소개 및 정의
• 주요 분석결과/진전
• 시장 예측(금액 기준) : 용도별(2020-2035년)
  • 연구
  • 임상
• 시장의 매력 : 용도별

제8장 세계 시장의 분석과 예측 : 적응증별

• 소개 및 정의
• 주요 분석결과/진전
• 시장 예측(금액 기준) : 적응증별(2020-2035년)
  • 근골격계장애
  • 심혈관질환
  • 종양학
  • 염증성질환 및 자가면역질환
  • 신경질환
  • 기타
• 시장의 매력 : 적응증별

제9장 세계 시장 분석 및 예측 : 최종사용자별

• 소개 및 정의
• 주요 분석결과/진전
• 시장 예측(금액 기준) : 최종사용자별(2020-2035년)
  • 병원
  • 제약 및 생명공학기업
  • 기타
• 시장의 매력 : 최종사용자별

제10장 세계 시장의 분석과 예측 : 지역별

• 주요 분석결과
• 시장 예측(금액 기준) : 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 시장의 매력 : 지역별

제11장 북미 시장의 분석과 예측

• 미국
• 캐나다

제12장 유럽 시장의 분석과 예측

• 독일
• 영국
• 프랑스
• 이탈리아
• 스페인
• 기타 유럽

제13장 아시아태평양시장의 분석과 예측

• 중국
• 일본
• 인도
• 호주 및 뉴질랜드
• 기타 아시아태평양

제14장 라틴아메리카 시장의 분석과 예측

• 브라질
• 멕시코
• 기타 라틴아메리카

제15장 중동 및 아프리카 시장의 분석과 예측

• GCC 국가
• 남아프리카
• 기타 중동 및 아프리카

제16장 경쟁 구도

• 시장 기업 및 경쟁 매트릭스(기업의 계층별 및 규모별)
• 시장 점유율 분석 : 기업별(2024년)
• 기업 프로파일
  • PromoCell
  • AcceGen
  • Bio-Techne
  • Cellular Engineering Technologies, Inc.
  • Merck KGaA
  • Lonza
  • Miltenyi Biotec
  • STEMCELL Technologies.
  • StemBioSys, Inc.
  • CORESTEMCHEMON Inc.
  • PHARMICELL Co., Ltd
  • BlueRock Therapeutics LP

영문목차

Stem Cells Market - Scope of Report

TMR's report on the global stem cells market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global stem cells market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global stem cells market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the stem cells market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global stem cells market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global stem cells market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global stem cells market.

The report delves into the competitive landscape of the global stem cells market. Key players operating in the global stem cells market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global stem cells market profiled in this report.

Key Questions Answered in Global stem cells Market Report:

• What is the sales/revenue generated by stem cells across all regions during the forecast period?
• What are the opportunities in the global stem cells market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Stem Cells Market - Research Objectives and Research Approach

The comprehensive report on the global stem cells market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global stem cells market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global stem cells market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Stem Cells Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Stem Cells Market Analysis and Forecasts, 2020 to 2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Key Industry Events (Partnerships, Collaborations, Mergers, Acquisitions, etc.)
• 5.2. Overview on Stem Cells
• 5.3. Pipeline Analysis
• 5.4. PORTER's Five Forces Analysis
• 5.5. PESTLE Analysis
• 5.6. Regulatory Scenario by Key Countries/Regions
• 5.7. Value Chain Analysis
• 5.8. Pricing Trends
• 5.9. Benchmarking of the Products Offered by the Leading Competitors
• 5.10. Go-to-Market Strategy for New Market Entrants

6. Global Stem Cells Market Analysis and Forecasts, By Cell Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Cell Type, 2020 to 2035
  • 6.3.1. Embryonic Stem Cells (ESCs)
  • 6.3.2. Mesenchymal Stem Cells (MSCs)
  • 6.3.3. Hematopoietic Stem Cells
  • 6.3.4. Induced Pluripotent Stem Cells (iPSCs)
  • 6.3.5. Others
• 6.4. Market Attractiveness By Cell Type

7. Global Stem Cells Market Analysis and Forecasts, By Application

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Application, 2020 to 2035
  • 7.3.1. Research
  • 7.3.2. Clinical
• 7.4. Market Attractiveness By Application

8. Global Stem Cells Market Analysis and Forecasts, By Indication

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Indication, 2020 to 2035
  • 8.3.1. Musculoskeletal Disorders
  • 8.3.2. Cardiovascular Disorders
  • 8.3.3. Oncology
  • 8.3.4. Inflammatory & Autoimmune Diseases
  • 8.3.5. Neurological Disorders
  • 8.3.6. Others
• 8.4. Market Attractiveness By Indication

9. Global Stem Cells Market Analysis and Forecasts, By End-user

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By End-user, 2020 to 2035
  • 9.3.1. Hospitals
  • 9.3.2. Pharmaceutical & Biotechnology Companies
  • 9.3.3. Others
• 9.4. Market Attractiveness By End-user

10. Global Stem Cells Market Analysis and Forecasts, By Region

• 10.1. Key Findings
• 10.2. Market Value Forecast By Region
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Region

11. North America Stem Cells Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Cell Type, 2020 to 2035
  • 11.2.1. Embryonic Stem Cells (ESCs)
  • 11.2.2. Mesenchymal Stem Cells (MSCs)
  • 11.2.3. Hematopoietic Stem Cells
  • 11.2.4. Induced Pluripotent Stem Cells (iPSCs)
  • 11.2.5. Others
• 11.3. Market Value Forecast By Application, 2020 to 2035
  • 11.3.1. Research
  • 11.3.2. Clinical
• 11.4. Market Value Forecast By Indication, 2020 to 2035
  • 11.4.1. Musculoskeletal Disorders
  • 11.4.2. Cardiovascular Disorders
  • 11.4.3. Oncology
  • 11.4.4. Inflammatory & Autoimmune Diseases
  • 11.4.5. Neurological Disorders
  • 11.4.6. Others
• 11.5. Market Value Forecast By End-user, 2020 to 2035
  • 11.5.1. Hospitals
  • 11.5.2. Pharmaceutical & Biotechnology Companies
  • 11.5.3. Others
• 11.6. Market Value Forecast By Country, 2020 to 2035
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Cell Type
  • 11.7.2. By Application
  • 11.7.3. By Indication
  • 11.7.4. By End-user
  • 11.7.5. By Country

12. Europe Stem Cells Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Cell Type, 2020 to 2035
  • 12.2.1. Embryonic Stem Cells (ESCs)
  • 12.2.2. Mesenchymal Stem Cells (MSCs)
  • 12.2.3. Hematopoietic Stem Cells
  • 12.2.4. Induced Pluripotent Stem Cells (iPSCs)
  • 12.2.5. Others
• 12.3. Market Value Forecast By Application, 2020 to 2035
  • 12.3.1. Research
  • 12.3.2. Clinical
• 12.4. Market Value Forecast By Indication, 2020 to 2035
  • 12.4.1. Musculoskeletal Disorders
  • 12.4.2. Cardiovascular Disorders
  • 12.4.3. Oncology
  • 12.4.4. Inflammatory & Autoimmune Diseases
  • 12.4.5. Neurological Disorders
  • 12.4.6. Others
• 12.5. Market Value Forecast By End-user, 2020 to 2035
  • 12.5.1. Hospitals
  • 12.5.2. Pharmaceutical & Biotechnology Companies
  • 12.5.3. Others
• 12.6. Market Value Forecast By Country/Sub-region, 2020 to 2035
  • 12.6.1. Germany
  • 12.6.2. UK
  • 12.6.3. France
  • 12.6.4. Italy
  • 12.6.5. Spain
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Cell Type
  • 12.7.2. By Application
  • 12.7.3. By Indication
  • 12.7.4. By End-user
  • 12.7.5. By Country/Sub-region

13. Asia Pacific Stem Cells Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Cell Type, 2020 to 2035
  • 13.2.1. Embryonic Stem Cells (ESCs)
  • 13.2.2. Mesenchymal Stem Cells (MSCs)
  • 13.2.3. Hematopoietic Stem Cells
  • 13.2.4. Induced Pluripotent Stem Cells (iPSCs)
  • 13.2.5. Others
• 13.3. Market Value Forecast By Application, 2020 to 2035
  • 13.3.1. Research
  • 13.3.2. Clinical
• 13.4. Market Value Forecast By Indication, 2020 to 2035
  • 13.4.1. Musculoskeletal Disorders
  • 13.4.2. Cardiovascular Disorders
  • 13.4.3. Oncology
  • 13.4.4. Inflammatory & Autoimmune Diseases
  • 13.4.5. Neurological Disorders
  • 13.4.6. Others
• 13.5. Market Value Forecast By End-user, 2020 to 2035
  • 13.5.1. Hospitals
  • 13.5.2. Pharmaceutical & Biotechnology Companies
  • 13.5.3. Others
• 13.6. Market Value Forecast By Country/Sub-region, 2020 to 2035
  • 13.6.1. China
  • 13.6.2. Japan
  • 13.6.3. India
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Cell Type
  • 13.7.2. By Application
  • 13.7.3. By Indication
  • 13.7.4. By End-user
  • 13.7.5. By Country/Sub-region

14. Latin America Stem Cells Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Cell Type, 2020 to 2035
  • 14.2.1. Embryonic Stem Cells (ESCs)
  • 14.2.2. Mesenchymal Stem Cells (MSCs)
  • 14.2.3. Hematopoietic Stem Cells
  • 14.2.4. Induced Pluripotent Stem Cells (iPSCs)
  • 14.2.5. Others
• 14.3. Market Value Forecast By Application, 2020 to 2035
  • 14.3.1. Research
  • 14.3.2. Clinical
• 14.4. Market Value Forecast By Indication, 2020 to 2035
  • 14.4.1. Musculoskeletal Disorders
  • 14.4.2. Cardiovascular Disorders
  • 14.4.3. Oncology
  • 14.4.4. Inflammatory & Autoimmune Diseases
  • 14.4.5. Neurological Disorders
  • 14.4.6. Others
• 14.5. Market Value Forecast By End-user, 2020 to 2035
  • 14.5.1. Hospitals
  • 14.5.2. Pharmaceutical & Biotechnology Companies
  • 14.5.3. Others
• 14.6. Market Value Forecast By Country/Sub-region, 2020 to 2035
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Cell Type
  • 14.7.2. By Application
  • 14.7.3. By Indication
  • 14.7.4. By End-user
  • 14.7.5. By Country/Sub-region

15. Middle East & Africa Stem Cells Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Cell Type, 2020 to 2035
  • 15.2.1. Embryonic Stem Cells (ESCs)
  • 15.2.2. Mesenchymal Stem Cells (MSCs)
  • 15.2.3. Hematopoietic Stem Cells
  • 15.2.4. Induced Pluripotent Stem Cells (iPSCs)
  • 15.2.5. Others
• 15.3. Market Value Forecast By Application, 2020 to 2035
  • 15.3.1. Research
  • 15.3.2. Clinical
• 15.4. Market Value Forecast By Indication, 2020 to 2035
  • 15.4.1. Musculoskeletal Disorders
  • 15.4.2. Cardiovascular Disorders
  • 15.4.3. Oncology
  • 15.4.4. Inflammatory & Autoimmune Diseases
  • 15.4.5. Neurological Disorders
  • 15.4.6. Others
• 15.5. Market Value Forecast By End-user, 2020 to 2035
  • 15.5.1. Hospitals
  • 15.5.2. Pharmaceutical & Biotechnology Companies
  • 15.5.3. Others
• 15.6. Market Value Forecast By Country/Sub-region, 2020 to 2035
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Cell Type
  • 15.7.2. By Application
  • 15.7.3. By Indication
  • 15.7.4. By End-user
  • 15.7.5. By Country/Sub-region

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Market Share Analysis By Company (2024)
• 16.3. Company Profiles
  • 16.3.1. PromoCell
    • 16.3.1.1. Company Overview
    • 16.3.1.2. Financial Overview
    • 16.3.1.3. Financial Overview
    • 16.3.1.4. Business Strategies
    • 16.3.1.5. Recent Developments
  • 16.3.2. AcceGen
    • 16.3.2.1. Company Overview
    • 16.3.2.2. Financial Overview
    • 16.3.2.3. Financial Overview
    • 16.3.2.4. Business Strategies
    • 16.3.2.5. Recent Developments
  • 16.3.3. Bio-Techne
    • 16.3.3.1. Company Overview
    • 16.3.3.2. Financial Overview
    • 16.3.3.3. Financial Overview
    • 16.3.3.4. Business Strategies
    • 16.3.3.5. Recent Developments
  • 16.3.4. Cellular Engineering Technologies, Inc.
    • 16.3.4.1. Company Overview
    • 16.3.4.2. Financial Overview
    • 16.3.4.3. Financial Overview
    • 16.3.4.4. Business Strategies
    • 16.3.4.5. Recent Developments
  • 16.3.5. Merck KGaA
    • 16.3.5.1. Company Overview
    • 16.3.5.2. Financial Overview
    • 16.3.5.3. Financial Overview
    • 16.3.5.4. Business Strategies
    • 16.3.5.5. Recent Developments
  • 16.3.6. Lonza
    • 16.3.6.1. Company Overview
    • 16.3.6.2. Financial Overview
    • 16.3.6.3. Financial Overview
    • 16.3.6.4. Business Strategies
    • 16.3.6.5. Recent Developments
  • 16.3.7. Miltenyi Biotec
    • 16.3.7.1. Company Overview
    • 16.3.7.2. Financial Overview
    • 16.3.7.3. Financial Overview
    • 16.3.7.4. Business Strategies
    • 16.3.7.5. Recent Developments
  • 16.3.8. STEMCELL Technologies.
    • 16.3.8.1. Company Overview
    • 16.3.8.2. Financial Overview
    • 16.3.8.3. Financial Overview
    • 16.3.8.4. Business Strategies
    • 16.3.8.5. Recent Developments
  • 16.3.9. StemBioSys, Inc.
    • 16.3.9.1. Company Overview
    • 16.3.9.2. Financial Overview
    • 16.3.9.3. Financial Overview
    • 16.3.9.4. Business Strategies
    • 16.3.9.5. Recent Developments
  • 16.3.10. CORESTEMCHEMON Inc.
    • 16.3.10.1. Company Overview
    • 16.3.10.2. Financial Overview
    • 16.3.10.3. Financial Overview
    • 16.3.10.4. Business Strategies
    • 16.3.10.5. Recent Developments
  • 16.3.11. PHARMICELL Co., Ltd
    • 16.3.11.1. Company Overview
    • 16.3.11.2. Financial Overview
    • 16.3.11.3. Financial Overview
    • 16.3.11.4. Business Strategies
    • 16.3.11.5. Recent Developments
  • 16.3.12. BlueRock Therapeutics LP
    • 16.3.12.1. Company Overview
    • 16.3.12.2. Financial Overview
    • 16.3.12.3. Financial Overview
    • 16.3.12.4. Business Strategies
    • 16.3.12.5. Recent Developments